Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Primary Care
Following abaloparatide use for osteoporosis treatment, how long do you consolidate with bisphosphonates before considering a drug holiday?
Answer from: at Community Practice
6 months
Sign In
or
Register
to read more
21202
Related Questions
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
How do you screen (imaging, modality) for bone density changes following oncologic treatment in childhood cancer survivors?
For patients <65 with significant intermittent steroid exposure who otherwise do not have risk factors for osteoporosis, when, if ever, do you recommend considering DEXA screening?
How do you approach osteoporosis screening in men?
In patients with history of breast cancer on aromatase inhibitor therapy, when do you transition off zolendronic acid therapy?
For which patients with hypophosphatasia do you recommend asfotase alfa therapy?
In patients with severe osteoporosis, history of retinal artery occlusion, and hypercalciuria, would you favor PTH analogue therapy or Evenity?
What is your approach to the management of chronic hyponatremia in the 131-134 range in ambulatory older adults?
Under what circumstances would you consider a bone biopsy in the workup of renal osteodystrophy?
Would you favor the use of denosumab over bisphosphonate therapy for treatment of osteoporosis in patients who are at high risk for osteoarthritis given recent data suggesting reduced risk of developing knee OA?